Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 12/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17821422 | 0.80 | MYC (1.00) | MYCSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL17821425 | 0.80 | MYC (1.00) | MYCSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL3435852 | 0.74 | MYC (0.58) | MYCSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL20362844 | 0.69 | MYC (0.69) | MYCSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL17821343 | 0.65 | MYC (1.00) | MYCSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL17821342 | 0.65 | MYC (1.00) | MYCSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL20362853 | 0.63 | MYC (0.68) | MYCSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL17834352 | 0.63 | MYC (1.00) | MYCSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL17834340 | 0.63 | MYC (0.81) | MYCSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL17821363 | 0.63 | MYC (1.00) | MYCSMN1; SMN2MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200048276-A9 | MYC MODULATORS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048276-A9 | MYC MODULATORS AND USES THEREOF | MYC, MYCBP, MYCBP2 | MYC 1/4885SMN1; SMN2 4149/4885MEN1 336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.